| LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL) (NCT00082225) | Baylor College of Medicine | 2003-10-01 |
| Gene Therapy ADA Deficiency (NCT01279720) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2003-10-01 |
| Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg (NCT00649181) | Mylan Pharmaceuticals Inc | 2003-10-01 |
| Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer (NCT00072787) | Taiho Oncology, Inc. | 2003-10-01 |
| Interaction Between Cocaine and Quetiapine - 1 (NCT00087750) | National Institute on Drug Abuse (NIDA) | 2003-10-01 |
| Amino Acid Therapy for Hot Flashes in Postmenopausal Women (NCT00081952) | National Center for Complementary and Integrative Health (NCCIH) | 2003-10-01 |
| Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (NCT00283088) | University of California, San Diego | 2003-10-01 |
| Topical Hydromorphone for Wound Healing (NCT00177060) | Hordinsky, Maria K., MD | 2003-10-01 |
| Vaccine Therapy in Treating Patients With Metastatic Breast Cancer (NCT00071942) | National Cancer Institute (NCI) | 2003-10-01 |
| Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions (NCT00834067) | Teva Pharmaceuticals USA | 2003-10-01 |
| Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma (NCT00076609) | PhytoCeutica | 2003-10-01 |
| Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions (NCT01149967) | Dr. Reddy's Laboratories Limited | 2003-10-01 |
| Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy (NCT00072137) | National Cancer Institute (NCI) | 2003-10-01 |
| Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions (NCT01124162) | Teva Pharmaceuticals USA | 2003-10-01 |
| S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction (NCT00049400) | SWOG Cancer Research Network | 2003-10-01 |
| Phase I/II, Open-Label Trial of Three Monoclonal Antibodies (NCT00219986) | Rockefeller University | 2003-10-01 |
| Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions (NCT00659074) | Par Pharmaceutical, Inc. | 2003-10-01 |
| Promoting Clinical Preventive Services Among Adults With Disabilities (NCT00164476) | Centers for Disease Control and Prevention | 2003-10-01 |
| Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00053183) | National Cancer Institute (NCI) | 2003-10-01 |
| An Electronic Pillbox for People With HIV (NCT00071500) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2 (NCT00199212) | Jules Bordet Institute | 2003-10-01 |
| Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus (NCT02254044) | Boehringer Ingelheim | 2003-10-01 |
| MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer (NCT00070837) | Millennium Pharmaceuticals, Inc. | 2003-10-01 |
| An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy (NCT00162201) | Bristol-Myers Squibb | 2003-10-01 |
| Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers (NCT00074308) | National Cancer Institute (NCI) | 2003-10-01 |
| Evaluation of Stereotactic Radiosurgery For Liver Malignancies (NCT00230347) | Stanford University | 2003-10-01 |
| The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress (NCT00174902) | Swiss Federal Institute of Technology | 2003-10-01 |
| E-Selectin Nasal Instillation to Prevent Secondary Stroke (NCT00069069) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-10-01 |
| AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme (NCT00107237) | Novartis Pharmaceuticals | 2003-10-01 |
| GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors (NCT00074022) | National Cancer Institute (NCI) | 2003-10-01 |
| Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) (NCT00390182) | University of Maryland, Baltimore | 2003-10-01 |
| Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer (NCT00291486) | Ludwig Institute for Cancer Research | 2003-10-01 |
| Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions (NCT00835042) | Teva Pharmaceuticals USA | 2003-10-01 |
| Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions (NCT01124175) | Teva Pharmaceuticals USA | 2003-10-01 |
| Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mg (NCT00649376) | Mylan Pharmaceuticals Inc | 2003-10-01 |
| Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. (NCT00424567) | Vericel Corporation | 2003-10-01 |
| An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease (NCT00357786) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-10-01 |
| Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors (NCT00125827) | Genzyme, a Sanofi Company | 2003-10-01 |
| Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors (NCT00070473) | Children's Oncology Group | 2003-10-01 |
| Allogenic Islet Cell Transplantation (NCT00160732) | University of Chicago | 2003-10-01 |
| Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients (NCT00284531) | Baylor College of Medicine | 2003-10-01 |
| Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions (NCT01149980) | Dr. Reddy's Laboratories Limited | 2003-10-01 |
| Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function (NCT01740362) | Pfizer | 2003-10-01 |
| A Transtheoretical Model Group Therapy for Cocaine (NCT00178776) | National Institute on Drug Abuse (NIDA) | 2003-10-01 |
| Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency (NCT02249442) | Boehringer Ingelheim | 2003-10-01 |
| Study of the Need for Temperature Probe Covers for Newborn Babies on Radiant Warmers (NCT00312065) | Maimonides Medical Center | 2003-10-01 |
| Teen Depression Awareness Project (TDAP) (NCT00099827) | RAND | 2003-10-01 |
| Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors (NCT00095160) | Masonic Cancer Center, University of Minnesota | 2003-10-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women (NCT03822078) | Amgen | 2003-09-30 |
| Seasonal Affective Depression (SAD) Study (NCT00069459) | GlaxoSmithKline | 2003-09-23 |
| Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML (NCT00195104) | Weill Medical College of Cornell University | 2003-09-17 |
| Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema (NCT00069056) | National Eye Institute (NEI) | 2003-09-10 |
| A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. (NCT00199836) | Ludwig Institute for Cancer Research | 2003-09-03 |
| ARQ 501 in Subjects With Cancer (NCT00075933) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2003-09-01 |
| Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia (NCT01894763) | Mayo Clinic | 2003-09-01 |
| Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00066456) | Gynecologic Oncology Group | 2003-09-01 |
| Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions (NCT00834639) | Teva Pharmaceuticals USA | 2003-09-01 |
| Nicotine Treatment of Mild Cognitive Impairment (MCI) (NCT00091468) | National Institute on Aging (NIA) | 2003-09-01 |
| Pilot Trial of Cognitive and Behavioral Treatment of Compulsive Hoarding Compared to Wait List Control (NCT00073346) | Boston University Charles River Campus | 2003-09-01 |
| Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer (NCT00057915) | Duke University | 2003-09-01 |
| GW406381 In Patients With Peripheral Nerve Injury (NCT00279032) | GlaxoSmithKline | 2003-09-01 |
| Safety Study of S-CKD602 in Patients With Advanced Malignancies (NCT00177281) | University of Pittsburgh | 2003-09-01 |
| Sublingual Methadone for the Management of Cancer Breakthrough Pain (NCT00125294) | AHS Cancer Control Alberta | 2003-09-01 |
| GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia (NCT00070551) | National Cancer Institute (NCI) | 2003-09-01 |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum (NCT00086931) | Roswell Park Cancer Institute | 2003-09-01 |
| IVIG - West Nile Encephalitis: Safety and Efficacy (NCT00068055) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-09-01 |
| LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma (NCT00062868) | Baylor College of Medicine | 2003-09-01 |
| Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions (NCT00836901) | Teva Pharmaceuticals USA | 2003-09-01 |
| Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions (NCT00972855) | Teva Pharmaceuticals USA | 2003-09-01 |
| Study of AS1411 in Advanced Solid Tumours (NCT00881244) | Antisoma Research | 2003-09-01 |
| Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858) | Fred Hutchinson Cancer Center | 2003-09-01 |
| Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension (NCT00853294) | Mallinckrodt | 2003-09-01 |
| Patient- and Physician-Based Osteoporosis Education (NCT00073190) | Brigham and Women's Hospital | 2003-09-01 |
| Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer (NCT00072098) | Max Sung | 2003-09-01 |
| Effects of Abdominal Hot Compresses on Indocyanine Green Elimination in Healthy Subjects (NCT00484913) | University Hospital Freiburg | 2003-09-01 |
| Cefprozil 500 mg Tablets Under Fed Conditions (NCT00840866) | Teva Pharmaceuticals USA | 2003-09-01 |
| A Study Of CP-690,550 In Stable Kidney Transplant Patients (NCT01710033) | Pfizer | 2003-09-01 |
| Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions. (NCT01131897) | Dr. Reddy's Laboratories Limited | 2003-09-01 |
| Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension (NCT00853190) | Mallinckrodt | 2003-09-01 |
| Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma (NCT00073736) | Ligand Pharmaceuticals | 2003-09-01 |
| Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer (NCT00070252) | National Cancer Institute (NCI) | 2003-09-01 |
| Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant (NCT00089453) | University of Arkansas | 2003-09-01 |
| Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions (NCT00834990) | Teva Pharmaceuticals USA | 2003-09-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer (NCT00281788) | Duke University | 2003-09-01 |
| CP-481,715 Nickel Allergy Study. (NCT00141180) | Pfizer | 2003-09-01 |
| Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer (NCT00135161) | University Hospital, Ghent | 2003-09-01 |
| A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina (NCT00350922) | University of Toronto | 2003-09-01 |
| Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors (NCT00072436) | National Cancer Institute (NCI) | 2003-09-01 |
| Empowering Elders Through Technology (NCT00261664) | Robert Wood Johnson Foundation | 2003-09-01 |
| Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions (NCT00973050) | Teva Pharmaceuticals USA | 2003-09-01 |
| Study of E7389 in Patients With Advanced Solid Tumors (NCT00069264) | Eisai Inc. | 2003-09-01 |
| Healthy Teen Girls: HIV Risk Reduction (NCT00787696) | Mississippi State University | 2003-09-01 |
| Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER (NCT00578708) | Abbott Medical Devices | 2003-09-01 |
| Cefprozil 500 mg Tablets Under Fasting Conditions (NCT00840281) | Teva Pharmaceuticals USA | 2003-09-01 |
| Take Rate, Immunogenicity and Safety of Elstree-BN Smallpox Vaccine in Healthy Vaccinia-Naive Subjects (NCT00189969) | Bavarian Nordic | 2003-09-01 |
| Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors (NCT00143533) | St. Jude Children's Research Hospital | 2003-09-01 |
| A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain (NCT00101790) | Icahn School of Medicine at Mount Sinai | 2003-09-01 |
| Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer (NCT00128999) | Alberta Health services | 2003-09-01 |
| EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) (NCT00078546) | Baylor College of Medicine | 2003-09-01 |
| Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy (NCT00374075) | University of Utah | 2003-09-01 |